These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26810716)

  • 1. Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production.
    Majewska-Szczepanik M; Askenase PW; Lobo FM; Marcińska K; Wen L; Szczepanik M
    J Allergy Clin Immunol; 2016 Jul; 138(1):262-273.e6. PubMed ID: 26810716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN.
    Fonseca DM; Paula MO; Wowk PF; Campos LW; Gembre AF; Turato WM; Ramos SG; Dias-Baruffi M; Barboza R; Gomes E; Horn C; Marchal G; Arruda LK; Russo M; Bonato VL
    Immunol Cell Biol; 2011 Oct; 89(7):777-85. PubMed ID: 21403663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
    Kumar MNK; Zhou C; Wu MX
    J Control Release; 2016 Aug; 235():82-90. PubMed ID: 27235977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
    J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells.
    Raker V; Stein J; Montermann E; Maxeiner J; Taube C; Reske-Kunz AB; Sudowe S
    Immunobiology; 2015 Apr; 220(4):490-9. PubMed ID: 25468560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antigen-independent but not antigen-specific T(H)1 response provides protection in the murine airway inflammation model.
    Burger MS; Zuleger CL; Chu Q; Gao X; Payne LG; Chen D
    J Allergy Clin Immunol; 2004 Dec; 114(6):1301-8. PubMed ID: 15577827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deviation of the allergic IgE to an IgG response by gene immunotherapy.
    Raz E; Spiegelberg HL
    Int Rev Immunol; 1999; 18(3):271-89. PubMed ID: 10614729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T regulatory cells 1 inhibit a Th2-specific response in vivo.
    Cottrez F; Hurst SD; Coffman RL; Groux H
    J Immunol; 2000 Nov; 165(9):4848-53. PubMed ID: 11046008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice.
    Ellertsen LK; Nygaard UC; Melkild I; Løvik M
    BMC Immunol; 2010 Mar; 11():8. PubMed ID: 20193059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1/Th2 balance in a murine model.
    Katayama S; Mine Y
    J Agric Food Chem; 2006 May; 54(9):3271-6. PubMed ID: 16637684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.
    Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y
    Pharm Res; 2005 Oct; 22(10):1627-33. PubMed ID: 16180119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses.
    Strid J; Callard R; Strobel S
    Immunology; 2006 Sep; 119(1):27-35. PubMed ID: 16764688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    Laouini D; Elkhal A; Yalcindag A; Kawamoto S; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2005 Aug; 116(2):390-6. PubMed ID: 16083795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis.
    Woodward AL; Spergel JM; Alenius H; Mizoguchi E; Bhan AK; Castigli E; Brodeur SR; Oettgen HC; Geha RS
    J Allergy Clin Immunol; 2001 Feb; 107(2):359-66. PubMed ID: 11174205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
    Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
    Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
    Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.